Regenerative potential of platelets in patients with chronic kidney disease.

Elżbieta Cecerska-HeryćRafał HeryćMagda WiśniewskaAnna MichalczykBarbara Dołęgowska

Published in: International urology and nephrology (2019)

The type of renal replacement therapy has a different effect on the concentration of platelet-derived growth factors IGF-1 and PDGF-B. PD patients had the highest concentrations of all growth factors, and this may be due to the presence of inflammation induced by dialysis-related advanced end-products of glycosylation (AGE).

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
stem cells
newly diagnosed
ejection fraction
oxidative stress
acute kidney injury
prognostic factors
patient reported outcomes
cell therapy
risk assessment
binding protein
human health
climate change
signaling pathway
growth hormone